Abstract
Multiple sclerosis (MS) is a chronic inflammatory disease of the central nervous system, with a complex genetic background. Here, we present a genome screen for association in small scale, employing 11,555 single nucleotide polymorphisms (SNPs) on DNA chips for genotyping 100 MS patients stratified for HLA-DR2+ and 100 controls. More than 500 SNPs revealed significant differences between cases and controls before Bonferroni correction. A fraction of these SNPs was reanalysed in two additional cohorts of patients and controls, using high-throughput genotyping methods. A marker on chromosome 6p21.32 (rs2395182) yielded the highest significance level, validating the established HLA-DR association.
Similar content being viewed by others
References
Hohlfeld R, Wekerle H (2001) Immunological update on multiple sclerosis. Curr Opin Neurol 14:299–304
Ebers GC, Bulman DE, Sadovnick AD, Paty DW, Warren S, Hader W, Murray TJ, Seland TP, Duquette P, Grey T, et al (1986) A population-based study of multiple sclerosis in twins. N Engl J Med 315:1638–1642
Epplen C, Jackel S, Santos EJ, D’Souza M, Poehlau D, Dotzauer B, Sindern E, Haupts M, Rude KP, Weber F, et al (1997) Genetic predisposition to multiple sclerosis as revealed by immunoprinting. Ann Neurol 41:341–352
Ebers GC, Sadovnick AD, Risch NJ (1995) A genetic basis for familial aggregation in multiple sclerosis. Canadian Collaborative Study Group. Nature 377:150–151
Casetta I, Granieri E (2000) Prognosis of multiple sclerosis: environmental factors. Neurol Sci 21:S839–S842
Weinshenker BG, Kantarci OH (2000) Seeking genes for MS: big risks for big gains. Neurology 54:542–544
Kalman B, Albert RH, Leist TP (2002) Genetics of multiple sclerosis: determinants of autoimmunity and neurodegeneration. Autoimmunity 35:225–234
GAMES; Transatlantic Multiple Sclerosis Genetics Cooperative (2003) A meta-analysis of whole genome linkage screens in multiple sclerosis. J Neuroimmunol 143:39–46
Kruglyak L (1999) Prospects for whole-genome linkage disequilibrium mapping of common disease genes. Nat Genet 22:139–144
Carlson CS, Eberle MA, Kruglyak L, Nickerson DA (2004) Mapping complex disease loci in whole-genome association studies. Nature 429:446–452
Botstein D, Risch N (2003) Discovering genotypes underlying human phenotypes: past successes for Mendelian disease, future approaches for complex disease. Nat Genet 33[Suppl]:228–237
Wall JD, Pritchard JK (2003) Haplotype blocks and linkage disequilibrium in the human genome. Nat Rev Genet 4:587–597
Shifman S, Kuypers J, Kokoris M, Yakir B, Darvasi A (2003) Linkage disequilibrium patterns of the human genome across populations. Hum Mol Genet 12:771–776
Wang WY, Todd JA (2003) The usefulness of different density SNP maps for disease association studies of common variants. Hum Mol Genet 12:3145–3149
Germer S, Holland MJ, Higuchi R (2000) High-throughput SNP allele-frequency determination in pooled DNA samples by kinetic PCR. Genome Res 10:258–266
Wolford JK, Blunt D, Ballecer C, Prochazka M (2000) High-throughput SNP detection by using DNA pooling and denaturing high performance liquid chromatography (DHPLC). Hum Genet 107:483–487
Myakishev MV, Khripin Y, Hu S, Hamer DH (2001) High-throughput SNP genotyping by allele-specific PCR with universal energy-transfer-labeled primers. Genome Res 11:163–169
Bray MS, Boerwinkle E, Doris PA (2001) High-throughput multiplex SNP genotyping with MALDI-TOF mass spectrometry: practice, problems and promise. Human Mutat 17:296–304
Hampe J, Wollstein A, Lu T, Frevel HJ, Will M, Manaster C, Schreiber S (2001) An integrated system for high throughput TaqMan-based SNP genotyping. Bioinformatics 17:654–655
Ohnishi Y, Tanaka T, Ozaki K, Yamada R, Suzuki H, Nakamura Y (2001) A high-throughput SNP typing system for genome-wide association studies. J Hum Genet 46:471–477
Jobs M, Howell WM, Stromqvist L, Mayr T, Brookes AJ (2003) DASH-2: flexible, low-cost, and high-throughput SNP genotyping by dynamic allele-specific hybridization on membrane arrays. Genome Res 13:916–924
Marnellos G (2003) High-throughput SNP analysis for genetic association studies. Curr Opin Drug Discov Dev 6:317–321
Consortium TIH (2003) The International HapMap project. Nature 426:789–796
Couzin J (2004) Genomics: consensus emerges on HapMap strategy. Science 304:671–673
Schmidt CW (2003) HapMap: building a database with blocks. EHP Toxicogenomics 111:A16
Goedde R, Sawcer S, Boehringer S, Miterski B, Sindern E, Haupts M, Schimrigk S, Compston A, Epplen JT (2002) A genome screen for linkage disequilibrium in HLA-DRB1*15-positive Germans with multiple sclerosis based on 4666 microsatellite markers. Hum Genet 111:270–277
Poser CM, Paty DW, Scheinberg L, McDonald WI, Davis FA, Ebers GC, Johnson KP, Sibley WA, Silberberg DH, Tourtellotte WW (1983) New diagnostic criteria for multiple sclerosis: guidelines for research protocols. Ann Neurol 13:227–231
Miller SA, Dykes DD, Polesky HF (1988) A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acids Res 16:1215
Matsuzaki H, Loi H, Dong S, Tsai YY, Fang J, Law J, Di X, Liu WM, Yang G, Liu G, et al (2004) Parallel genotyping of over 10,000 SNPs using a one-primer assay on a high-density oligonucleotide array. Genome Res 14:414–425
Sasieni PD (1997) From genotypes to genes: doubling the sample size. Biometrics 53:1253–1261
Excoffier L, Slatkin M (1995) Maximum-likelihood estimation of molecular haplotype frequencies in a diploid population. Mol Biol Evol 12:921–927
Hawley ME, Kidd KK (1995) HAPLO: a program using the EM algorithm to estimate the frequencies of multi-site haplotypes. J Heredity 86:409–411
Rohde K, Fuerst R (2001) Haplotyping and estimation of haplotype frequencies for closely linked biallelic multilocus genetic phenotypes including nuclear family information. Human Mutat 17:289–295
Wu J, Williams TM (2002) DRB1/3/5 locus sequence based allele identification. International Histocompatibility Working Group (IHWG), Seattle
Bennetts BH, Teutsch SM, Buhler MM, Heard RN, Stewart GJ (1999) HLA-DMB gene and HLA-DRA promoter region polymorphisms in Australian multiple sclerosis patients. Hum Immunol 60:886–893
Janecke AR, Thompson DA, Utermann G, Becker C, Hubner CA, Schmid E, McHenry CL, Nair AR, Ruschendorf F, Heckenlively J, et al (2004) Mutations in RDH12 encoding a photoreceptor cell retinol dehydrogenase cause childhood-onset severe retinal dystrophy. Nat Genet 36:850–854
Kaindl AM, Rüschendorf F, Krause S, Goebel H-H, Koehler K, Becker C, Pongratz D, Müller-Höcker J, Nürnberg P, Stoltenburg-Didinger G, et al (2004) Missense mutations of ACTA1 cause dominant congenital myopathy with cores. Med Genet 41:842–848
Uhlenberg B, Schuelke M, Ruschendorf F, Ruf N, Kaindl AM, Henneke M, Thiele H, Stoltenburg-Didinger G, Aksu F, Topaloglu H, et al (2004) Mutations in the gene encoding gap junction protein alpha 12 (connexin 46.6) cause Pelizaeus–Merzbacher-like disease. Am J Hum Genet 75:251-260
Gabriel SB, Schaffner SF, Nguyen H, Moore JM, Roy J, Blumenstiel B, Higgins J, DeFelice M, Lochner A, Faggart M, et al (2002) The structure of haplotype blocks in the human genome. Science 296:2225–2229
Alizadeh M, Genin E, Babron MC, Birebent B, Cournu-Rebeix I, Yaouanq J, Dreano S, Sawcer S, Compston A, Clanet M, et al (2003) Genetic analysis of multiple sclerosis in Europeans: French data. J Neuroimmunol 143:74–78
Barcellos LF, Oksenberg JR, Begovich AB, Martin ER, Schmidt S, Vittinghoff E, Goodin DS, Pelletier D, Lincoln RR, Bucher P, et al (2003) HLA-DR2 dose effect on susceptibility to multiple sclerosis and influence on disease course. Am J Hum Genet 72:710–716
Bielecki B, Mycko MP, Tronczynska E, Bieniek M, Sawcer S, Setakis E, Benediktsson K, Compston A, Selmaj KW (2003) A whole genome screen for association in Polish multiple sclerosis patients. J Neuroimmunol 143:107–111
Coraddu F, Sawcer S, Feakes R, Chataway J, Broadley S, Jones HB, Clayton D, Gray J, Smith S, Taylor C et al (1998) HLA typing in the United Kingdom multiple sclerosis genome screen. Neurogenetics 2:24–33
Haines JL, Terwedow HA, Burgess K, Pericak-Vance MA, Rimmler JB, Martin ER, Oksenberg JR, Lincoln R, Zhang DY, Banatao DR et al (1998) Linkage of the MHC to familial multiple sclerosis suggests genetic heterogeneity: the multiple sclerosis genetics group. Hum Mol Genet 7:1229–1234
Ligers A, Dyment DA, Willer CJ, Sadovnick AD, Ebers G, Risch N, Hillert J (2001) Evidence of linkage with HLA-DR in DRB1*15-negative families with multiple sclerosis. Am J Hum Genet 69:900–903
Martin R (1997) Genetics of multiple sclerosis—how could disease-associated HLA-types contribute to pathogenesis? J Neural Transm Suppl 49:177–194
Bayley JP, Ottenhoff TH, Verweij CL (2004) Is there a future for TNF promoter polymorphisms? Genes Immun 5:315–329
Acknowledgements
This study was supported by the Hertie Stiftung (Frankfurt, Germany, project no. 1.319.110/02/05) and the German Federal Ministry of Science and Education through the National Genome Research Network (NGFN grant 01GR0104). The skilful technical assistance of A. Petzold and K. Schlang are gratefully acknowledged.
Author information
Authors and Affiliations
Corresponding author
Additional information
P. Nürnberg and J.T. Epplen contributed equally.
Rights and permissions
About this article
Cite this article
Gödde, R., Rohde, K., Becker, C. et al. Association of the HLA region with multiple sclerosis as confirmed by a genome screen using >10,000 SNPs on DNA chips. J Mol Med 83, 486–494 (2005). https://doi.org/10.1007/s00109-005-0650-8
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00109-005-0650-8